BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3221907)

  • 1. Purified glycoproteins of influenza virus stimulate cell-mediated cytotoxicity in vivo.
    Arora DJ; Houde M
    Nat Immun Cell Growth Regul; 1988; 7(5-6):287-96. PubMed ID: 3221907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human influenza viral neuraminidases augment cell-mediated cytotoxicity in vitro.
    Arora DJ; Justewicz DM
    Nat Immun Cell Growth Regul; 1988; 7(2):87-94. PubMed ID: 3412358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of human natural killer cytotoxicity by influenza virus and its subunit protein.
    Ali SA; Rees RC; Oxford J
    Immunology; 1984 Aug; 52(4):687-95. PubMed ID: 6746000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of murine macrophage responses stimulated with influenza glycoproteins.
    Arora DJ; Houde M
    Can J Microbiol; 1992 Mar; 38(3):188-92. PubMed ID: 1393819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza virus-specific T cell-mediated cytotoxicity: integration of the virus antigen into the target cell membrane is essential for target cell formation.
    Kurrle R; Wagner H; Röllinghoff M; Rott R
    Eur J Immunol; 1979 Feb; 9(2):107-11. PubMed ID: 312203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
    Johansson BE; Kilbourne ED
    Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
    J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
    J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enhancement of the immune response to surface antigens of the influenza B virus as a result of their covalent binding with a synthetic polymer carrier].
    Petrov RV; Zhdanov VM; Kabanov VA; Khaitov RM; Norimov ASh
    Biull Eksp Biol Med; 1985 Feb; 99(2):184-6. PubMed ID: 4038611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
    Stein-Streilein J; Bennett M; Mann D; Kumar V
    J Immunol; 1983 Dec; 131(6):2699-704. PubMed ID: 6644021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface glycoproteins of influenza virus increase cell-mediated immunity functions in mice.
    Del Gobbo V; Villani N; Balestra E; Marini S; Firriolo A; Caliò R
    Boll Ist Sieroter Milan; 1987; 66(1):1-8. PubMed ID: 3497649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
    Wright SC; Bonavida B
    J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins.
    Ze C; Kurata T; Tamura S
    Jpn J Infect Dis; 2000 Dec; 53(6):219-28. PubMed ID: 11227019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of age-related changes in natural killer cells during primary influenza infection in mice.
    Nogusa S; Ritz BW; Kassim SH; Jennings SR; Gardner EM
    Mech Ageing Dev; 2008 Apr; 129(4):223-30. PubMed ID: 18304606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.